This Week in HIV Research: Monday, Wednesday, Treatment Days

This Week in HIV Research: Monday, Wednesday, Treatment Days

1 of 5
Next >

We're not sure whether an HIV research publication has ever made a Happy Days reference in an article headline before, but if we're the first, we have no regrets.

When we punched the medical journal jukebox this week, these new hits played:

  • A maintenance regimen consisting of efavirenz/emtricitabine/tenofovir disoproxil fumarate (Atripla) taken just three days a week -- Monday, Wednesday, and Friday.
  • Insufficient use of chronic opioid therapy monitoring by care providers of people living with HIV.
  • A hint of uncertainty regarding neurocognitive benefits of immediate HIV treatment among people with a high CD4 count.
  • Signs that CD4 count affects influenza virus shedding among people with HIV.

To beat HIV, you have to follow the science, right? Exactamundo!

Barbara Jungwirth is a freelance writer and translator based in New York. Follow Barbara on Twitter: @reliabletran.

Myles Helfand is the executive editor and general manager of TheBody.com and TheBodyPRO.com. Follow Myles on Twitter: @MylesatTheBody.

Image Credit: ABCUploaded [Public domain], via Wikimedia Commons

We're not sure whether an HIV research publication has ever made a Happy Days reference in an article headline before, but if we're the first, we have no regrets.

When we punched the medical journal jukebox this week, these new hits played:

  • A maintenance regimen consisting of efavirenz/emtricitabine/tenofovir disoproxil fumarate (Atripla) taken just three days a week -- Monday, Wednesday, and Friday.
  • Insufficient use of chronic opioid therapy monitoring by care providers of people living with HIV.
  • A hint of uncertainty regarding neurocognitive benefits of immediate HIV treatment among people with a high CD4 count.
  • Signs that CD4 count affects influenza virus shedding among people with HIV.

To beat HIV, you have to follow the science, right? Exactamundo!

Barbara Jungwirth is a freelance writer and translator based in New York. Follow Barbara on Twitter: @reliabletran.

Myles Helfand is the executive editor and general manager of TheBody.com and TheBodyPRO.com. Follow Myles on Twitter: @MylesatTheBody.

Image Credit: ABCUploaded [Public domain], via Wikimedia Commons